BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23506690)

  • 1. Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial.
    Zhai XF; Chen Z; Li B; Shen F; Fan J; Zhou WP; Yang YK; Xu J; Qin X; Li LQ; Ling CQ
    J Integr Med; 2013 Mar; 11(2):90-100. PubMed ID: 23506690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study.
    Zhai XF; Liu XL; Shen F; Fan J; Ling CQ
    Cancer; 2018 May; 124(10):2161-2168. PubMed ID: 29499082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of jiedu granules combined with cinobufacini injection versus transcatheter arterial chemoembolization in post-surgical patients with hepatocellular carcinoma: a case-control trial.
    Chen Z; Chen HY; Lang QB; Li B; Zhai XF; Guo YY; Yue XQ; Ling CQ
    Chin J Integr Med; 2012 May; 18(5):339-44. PubMed ID: 22549390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study.
    Xu X; Chen R; Chen Q; An K; Ding L; Zhang L; Wang F; Deng Y
    Complement Ther Clin Pract; 2021 May; 43():101359. PubMed ID: 33711747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
    Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Transarterial Chemoembolization in Combination With Kang'ai Injection on Patients With Intermediate Stage Hepatocellular Carcinoma: A Prospective Study.
    Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Yang M; Wu XN
    Integr Cancer Ther; 2018 Jun; 17(2):477-485. PubMed ID: 29108428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
    Bruix J; Takayama T; Mazzaferro V; Chau GY; Yang J; Kudo M; Cai J; Poon RT; Han KH; Tak WY; Lee HC; Song T; Roayaie S; Bolondi L; Lee KS; Makuuchi M; Souza F; Berre MA; Meinhardt G; Llovet JM;
    Lancet Oncol; 2015 Oct; 16(13):1344-54. PubMed ID: 26361969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety.
    Wei W; Jian PE; Li SH; Guo ZX; Zhang YF; Ling YH; Lin XJ; Xu L; Shi M; Zheng L; Chen MS; Guo RP
    Cancer Commun (Lond); 2018 Oct; 38(1):61. PubMed ID: 30305149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial.
    Cheng BQ; Jia CQ; Liu CT; Fan W; Wang QL; Zhang ZL; Yi CH
    JAMA; 2008 Apr; 299(14):1669-77. PubMed ID: 18398079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial.
    Zheng DH; Yang JM; Wu JX; Cheng SQ; Zhang SG; Wu D; Li AJ; Fu XH; Li X; Qi FC; Duan WH; Chen JH; Yang ZY; Liang L; Zeng JX; Zheng WD; Wu MC
    Chin J Integr Med; 2023 Jan; 29(1):3-9. PubMed ID: 35915317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese herbal medicine, Jianpi Ligan decoction, improves prognosis of unresectable hepatocellular carcinoma after transarterial chemoembolization: a retrospective study.
    Tang CW; Zhu M; Feng WM; Bao Y; Zheng YY
    Drug Des Devel Ther; 2016; 10():2461-6. PubMed ID: 27536066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
    Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
    Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.
    Sun JJ; Wang K; Zhang CZ; Guo WX; Shi J; Cong WM; Wu MC; Lau WY; Cheng SQ
    Ann Surg Oncol; 2016 Apr; 23(4):1344-51. PubMed ID: 26714945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
    Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative transarterial chemoembolization for hepatocellular carcinoma.
    Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguchi T
    Hepatogastroenterology; 2012 Oct; 59(119):2295-9. PubMed ID: 23435144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
    Murakami T; Ishimaru H; Sakamoto I; Uetani M; Matsuoka Y; Daikoku M; Honda S; Koshiishi T; Fujimoto T
    Cardiovasc Intervent Radiol; 2007; 30(4):696-704. PubMed ID: 17497071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
    J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
    Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
    Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.